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Abstract
Background: Changes in the microvasculature associated with pre-eclampsia and gestational hypertension have
been proposed as a potential pathway in the development of cardiovascular disease. We examined whether
gestational hypertensive disorders, such as pre-eclampsia and gestational hypertension, are related to the maternal
retinal microvasculature status after pregnancy.
Methods: This study is part of an ongoing population-based prospective cohort study. During pregnancy and
6.2 years after the index pregnancy (90% range 5.7–7.4 years), we examined 3391 women with available
information on pre-eclampsia, gestational hypertension, and retinal vascular calibers. Retinal arteriolar and
venular calibers were measured in the left eye from digitized retinal photographs.
Results: Women with pre-eclampsia had smaller retinal arteriolar calibers 6 years after pregnancy than women
with a normotensive pregnancy (adjusted difference: –0.40 standard deviation score [SDS]; 95% confidence
interval [CI]: –0.62, –0.19). For women with previous gestational hypertension, similar trends were observed
(–0.20 SDS; 95% CI: –0.34, –0.05). With respect to retinal venular calibers, we did not observe consistent trends
for women with previous pre-eclampsia. However, in women with previous gestational hypertension, we
observed larger venular calibers (0.22 SDS; 95% CI: 0.07–0.36) than in women with a previous normotensive
pregnancy. The association of gestational hypertensive disorders with retinal vessel calibers was mediated
through mean arterial pressure at the time of retinal imaging.
Conclusions: Compared to women with a previous normotensive pregnancy, women with pre-eclampsia and
gestational hypertension show an altered status of the microvasculature 6 years after the index pregnancy. This
is reflected by smaller retinal arteriolar calibers and wider retinal venular calibers. These microvascular changes
may possibly contribute to the development of cardiovascular disease in later life.
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Background
Gestational hypertensive disorders (GHD) (e.g., pre-
eclampsia [PE] and gestational hypertension [GH]) affect
7% of pregnancies today [1, 2]. Both disorders are char-
acterized by new onset of hypertension after 20 weeks of
gestation and, in the case of PE, proteinuria. All features
of GHD were previously believed to resolve after
delivery. However, results from a large meta-analysis
show that women with a history of GHD have a twofold
to sevenfold increased risk of developing cardiovascular
disease (CVD) in later life [3]. The exact pathophysio-
logic mechanism underlying this increased CVD risk re-
mains unclear. Nevertheless, it has been shown that
microvascular endothelial dysfunction as reflected by a
reduced brachial artery flow-mediated dilatation persists
in former pre-eclamptic women for many years after
their index pregnancy [4]. These data suggest that the
microvasculature may have been affected by GHD and
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therefore forms an important link between GHD and
the development of CVD in later life.
In recent years, retinal vascular imaging has emerged
as a non-invasive technique to visualize the microvascu-
lature [5–7]. Using this technique in individuals over
50 years of age, several studies have shown that micro-
vascular pathology is an independent contributor to the
development of CVD in later life, especially in women
[8]. Furthermore, a recent study examining the vasodila-
tory response of retinal vessels to flicker light showed
that women with PE had reduced arteriolar vasodilata-
tion during and after pregnancy compared to women
with a normotensive pregnancy, indicating that micro-
vascular dysfunction may already start early in life [9].
Examining the retinal microvasculature may provide fur-
ther insight into why women with previous GHD have
an increased risk for developing CVD later in life.
In the current study we investigated the association
between a history of GHD and the status of the micro-
vasculature 6 years after the index pregnancy, as
reflected by retinal vascular calibers, in women between
the ages of 24 to 36 years.
Methods
Design and study population
This study was embedded in the Generation R Study, a
population-based prospective cohort study from early
pregnancy onwards in Rotterdam, the Netherlands
[10, 11]. The study has been approved by the Medical
Ethics Committee of the Erasmus University Medical
Center (Erasmus MC), Rotterdam, the Netherlands,
and the procedures followed were in accordance with
institutional guidelines [12]. Written informed consent
was obtained from all participants. For the present
study we included women with a live born singleton
with available information on GHD and on postnatal
follow-up data. Women were excluded from the main
analyses when they had a history of chronic hyperten-
sion prior to enrollment in the Generation R Study.
We also excluded women who were pregnant during
follow-up and women without information on retinal
vascular calibers during the follow-up visit 6 years
after the index pregnancy. The final population for
analysis comprised 3391 women (Fig. 1).
Gestational hypertensive disorders
The presence of doctor-diagnosed PE or GH was re-
trieved from hospital charts and was determined on the
basis of the former criteria described by the Inter-
national Society for the Study of Hypertension in
Pregnancy of 2001 [13, 14]. GH was defined by a systolic
blood pressure ≥140 mmHg or a diastolic blood pressure
≥90 mmHg after 20 weeks of gestation in previously
normotensive women. PE was defined as de novo GH with
concurrent new onset proteinuria in a random urine sam-
ple with no evidence of urinary tract infection [13].
Maternal blood pressure and anthropometrics
Blood pressure was measured at study enrollment
(median 13.2 weeks of gestation [90% range 10.6–
17.0 weeks]) and 6 years after the index pregnancy
(90% range, 5.7–7.4 years) as the average of two sys-
tolic and diastolic blood pressure readings, with the
validated Omron 907 automated digital oscillometric
sphygmomanometer (OMRON Healthcare Europe
B.V., Hoofddorp, the Netherlands) [15].
All participants were in a standardized supine position
to prevent differences due to position. A cuff was placed
around the right upper arm. In case of an upper arm ex-
ceeding 33 cm, a larger cuff (32–42 cm) was used. The
mean value of two blood pressure readings over a 5-min
interval was documented for each participant. Blood
pressure was measured by trained research assistants
wearing normal clothing (i.e., no white coat). Mean ar-
terial pressure (MAP) 6 years after pregnancy was cal-
culated as the average systolic blood pressure plus two
times the average diastolic blood pressure, divided by
3. Hypertension 6 years after the index pregnancy was
defined by the average of two consecutive blood pres-
sure readings, with systolic blood pressure ≥140 mmHg
Fig. 1 Flowchart of women involved in the study
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and/or diastolic blood pressure ≥90 mmHg or the use
of antihypertensive medication [16]. Using an alterna-
tive cut-off, with systolic blood pressure ≥130 mmHg
and/or diastolic blood pressure ≥80 mmHg, did not
change the direction of our results but attenuated our
results to non-significant levels.
At study enrollment maternal height (in centimeters)
and weight (in kilograms) without shoes were measured,
after which body mass index (BMI) (in kilograms/meter
squared) was calculated. Identical measurements were
obtained during follow-up 6 years after pregnancy. Pre-
pregnancy BMI was established at enrollment through a
questionnaire. Pre-pregnancy weight was highly correlated
with the measured early pregnancy weight (Pearson’s cor-
relation coefficient r 0.95 [P < 0.001]) [17].
Retinal vascular caliber assessment
Retinal vascular calibers were assessed by taking digital
retinal photographs 6 years after the index pregnancy.
Unilateral and unfractionated photographs were taken of
the left eye by a Topcon digital retinal camera (model
TRC, NW300) while centered on the optic disk. The
resolution of the images was set to 4096 and 3072 pixels.
Additionally, a semi‐automatic computer‐imaging pro-
gram was used to measure the six largest retinal arteri-
olar and venular calibers of the photos. These calibers
were located one half to one disk diameter from the
optic disk margin [18]. The averages of the six largest
retinal arteriolar and retinal venular calibers were then
summarized as central retinal arteriolar and central ret-
inal venular equivalents [19]. The semi‐automatic com-
puter‐imaging program that was used for computation
of the central retinal arteriolar and central retinal venu-
lar equivalents was operated by two graders who were
blinded to participants’ characteristics. Grader-specific
standard deviation scores (SDSs) were used for both
central retinal arteriolar and central retinal venular
equivalents. Intraclass correlation coefficients between
both graders were excellent for both retinal arteriolar
calibers (0.77; 95% confidence interval [CI]: 0.69–0.84)
and retinal venular calibers (0.87; 95% CI: 0.81–0.91).
This suggests adequate reproducibility.
Covariates
Information on maternal characteristics during pregnancy,
including maternal age, self-reported pre-pregnancy weight,
gravidity, parity, ethnicity, educational level, smoking, and
chronic hypertension, was available from questionnaires re-
peatedly applied during pregnancy. Information on gesta-
tional age at birth, birth weight, and child sex was obtained
from medical records [20, 21]. Six years after the index
pregnancy, we obtained information, through question-
naires, on gravidity and parity at follow-up, medication in-
take, and smoking.
Statistical analysis
We performed four types of analyses. First, a non-
response analysis was performed by comparing subject
characteristics between mothers with and mothers with-
out available follow-up data 6 years after the index
pregnancy (Additional file 1). Women with available
follow-up data, but without information on retinal vas-
cular calibers, were left out of the non-response analysis.
Second, to reduce the possibility of potential bias associ-
ated with missing data, missing values in covariates were
imputed using multiple imputation procedures. Five
draws for each missing value were performed providing
five substituted data points, which in turn created five
completed datasets. Analyses were performed separately
on each completed dataset and thereafter combined into
one global result [22]. In the total population for ana-
lysis, 19.4% had missing information on pre-pregnancy
BMI, 2.3% on ethnicity, 6.7% on education, 11.3% on
smoking during pregnancy, 29.5% on gravidity at follow-
up, 29.9% on smoking during follow-up, 2.3% on blood
pressure during follow-up, and 0.2% on medication in-
take during follow-up. Third, differences in maternal
characteristics during pregnancy and follow-up were
compared between women with GHD and women with
normotensive pregnancies using one-way analysis of
variance (ANOVA) for continuous variables and chi-
square tests for categorical variables. Fourth, associations
between GHD, normotensive pregnancies, and retinal
vascular calibers were assessed through linear regression.
The linear regression model included covariates selected
based on their associations with the outcome of interest
based on previous studies or a change in effect estimate
of >10% (maternal age at enrollment, ethnicity, educa-
tional level at enrollment, smoking during pregnancy,
and pre-pregnancy BMI; lastly, when assessing retinal ar-
teriolar caliber, we additionally adjusted for retinal venu-
lar caliber and vice versa. GHD are known to increase
blood pressure, and blood pressure is known to be asso-
ciated with smaller retinal arteriolar calibers [23]. To
examine the mediating role of mean arterial blood pres-
sure at the time of retinal imaging in the association of
GHD with retinal vascular calibers, we analyzed the dir-
ect and indirect causal mediation effects through medi-
ation analyses [24]. We used the full model, as was used
for linear regression analysis, to adjust for confounding.
Statistical analyses were performed using the Statistical
Package for the Social Sciences version 21.0 for
Windows (SPSS Inc., Chicago, IL, USA) and R version
3.3.2 (R foundation for Statistical Computing, Vienna,
Austria [packages ‘foreign’, ‘rms’ and ‘mediation’]) [25].
Results
Tables 1 and 2 show maternal characteristics during
pregnancy and 6 years after the index pregnancy.
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Women with GHD had higher systolic and diastolic
blood pressures at the start of pregnancy and 6 years
later compared to women with a normotensive preg-
nancy. Additionally, women with a history of GHD had
hypertension more often and were more likely to take
cardiovascular or antihypertensive medication 6 years
after pregnancy compared to women with a normoten-
sive pregnancy.
Table 3 and Additional file 2: Figure S1A and S1B
show that women with PE had smaller retinal arteriolar
calibers 6 years after pregnancy than women with a pre-
vious normotensive pregnancy (age-adjusted difference:
–0.49 SDS; 95% CI –0.74, –0.25). Additional adjustment
for ethnicity, educational level, smoking, pre-pregnancy
BMI, and retinal venular caliber did not alter these re-
sults. Women with GH also had smaller retinal arteriolar
calibers than women with a previous normotensive preg-
nancy (fully adjusted difference: –0.20 SDS; 95% CI –
0.34, –0.05). Women with previous PE did not show any
difference in retinal venular calibers 6 years after preg-
nancy compared to those with a normotensive preg-
nancy. However, retinal venular calibers were larger in
women with GH than in those with a previous normo-
tensive pregnancy (0.22 SDS; 95% CI 0.07–0.36).
The results of mediation analyses for the mediating
role of MAP at the time of retinal imaging in the
association of GHD with retinal vessel calibers are pre-
sented in Table 4. There was mediation by MAP in the
association of both PE and GH with retinal arteriolar
and retinal venular calibers.
Finally, we tested whether the amount of previous
pregnancies affected our results. No differences were ob-
served in retinal vascular calibers in association with
gravidity or parity.
Discussion
Our study shows that women with GHD have an altered
status of the retinal microvasculature 6 years after the
index pregnancy compared to women with a normoten-
sive index pregnancy. In particular, women with PE have
smaller retinal arteriolar calibers than women with pre-
vious normotensive pregnancies. Additionally, women
with GH have wider retinal venular calibers than women
with previous normotensive pregnancies. These associ-
ations may partly be related to concurrent blood pres-
sure, since adjustment for MAP attenuated most
relationships.
During a normotensive pregnancy, the maternal car-
diovascular system undergoes imperative adaptations by
increasing intravascular volume, heart rate, and cardiac
output [26]. Concomitantly with these cardiovascular
adaptations, there is a decrease in blood pressure
Table 1 Subject characteristics by gestational hypertensive disorder (n = 3391)
Normotensive pregnancy GH PE P value
(n = 3183) (n = 145) (n = 63)
Maternal characteristics (pregnancy)
Age at enrollment (years) 30.1 (5.1) 30.4 (5.1) 29.4 (5.5) 0.44
Gestational age at enrollment (weeks) 13.9 (10.9, 22.2) 13.4 (10.1, 22.9) 13.8 (10.3, 22.5) 0.15
Height (cm) 166.6 (7.4) 168.0 (7.3) 165.3 (6.8) 0.03
Pre-pregnancy weight (kg) 64.0 (50.0, 87.0) 70.0 (54.0, 114.4) 68.0 (53.2, 105.0) <0.001
Pre-pregnancy body mass index (kg/m2) 22.7 (18.7, 31.5) 25.2 (20.0, 40.2) 24.4 (19.2, 37.2) <0.001
Weight at enrollment (kg) 67.0 (52.8, 91.1) 75.0 (56.3, 112.0) 70.0 (52.0, 110.4) <0.001
Systolic blood pressure at enrollment (mmHg) 114.8 (11.7) 126.0 (13.1) 120.4 (12.9) <0.001
Diastolic blood pressure at enrollment (mmHg) 67.3 (9.0) 76.7 (11.3) 74.3 (9.9) <0.001
Primiparous (no., %) 1894 (60.0) 110 (75.9) 51 (81.0) <0.001
Non-European ethnicity (no., %) 1267 (40.8) 42 (29.0) 30 (47.6) 0.005
Lower educational level (no., %) 272 (9.2) 11 (7.9) 6 (10.0) 0.02
Smoking (no., %) 749 (26.6) 43 (32.1) 13 (21.3) 0.29
Pregnancy outcomes
Gestational age at birth (weeks) 40.1 (37.1, 42.1) 40.1 (37.2, 42.1) 38.6 (30.9, 41.5) <0.001
Birth weight (g) 3442.1 (539.8) 3432.8 (578.6) 2889.3 (877.4) <0.001
Small for gestational age < p10 (no., %) 296 (9.3) 20 (13.8) 17 (27.0) <0.001
Male sex (no., %) 1624 (51.0) 76 (52.4) 25 (39.7) 0.19
Values are percentages for categorical variables, means (SD) for continuous variables with a normal distribution, or medians (90% range) for continuous variables
with a skewed distribution. Differences in baseline characteristics were tested using Student’s t test, ANOVA, Kruskal-Wallis, and chi-square tests. Presented values
are not imputed
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accompanied by physiologic vasodilatation of the micro-
vasculature [27]. Cross-sectional results from the Growing
Up in Singapore Towards Healthy Outcomes (GUSTO)
study support these adaptations, showing that each
10 mmHg increase in MAP during pregnancy was associ-
ated with a significant reduction in retinal arteriolar cali-
ber, especially for MAP ≥90 mmHg [28]. Another study,
using retinal images obtained throughout pregnancy
and 6 months after pregnancy of 53 normotensive
women, also demonstrated changes in the retinal mi-
crovasculature over the course of a normotensive
pregnancy in conjunction with blood pressure adapta-
tions [29]. During mid-pregnancy, when blood pressure
shows a physiologic decrease, retinal arteriolar and reti-
nal venular calibers increased significantly. Neverthe-
less, retinal arteriolar and venular calibers returned to
normal (early pregnancy) values in late pregnancy and
6 months after pregnancy. These results imply that
changes in the retinal microvasculature during preg-
nancy are transient and mainly the consequence of
concurrent physiologic blood pressure fluctuations.
However, other studies in non-pregnant populations
Table 3 Associations of gestational hypertensive disorders with retinal vascular calibers 6 years after index pregnancy (n = 3391)
Normotensive pregnancy
(n = 3183)
Gestational hypertension (n = 145)
Beta (95% CI)
P value Pre-eclampsia (n = 63)
Beta (95% CI)
P value
Retinal arteriolar caliber (SDS)
Full model Ref –0.20 (–0.34, –0.05) 0.007 –0.40 (–0.62, –0.19) 0.0002
Retinal venular caliber (SDS)
Full model Ref 0.22 (0.07–0.36) 0.003 0.08 (–0.13, 0.30) 0.45
CI confidence interval, Ref reference, SDS standard deviation score
Values are regression coefficients (95% CI) and are based on linear regression. Estimates are from multiple imputed data. Full model: adjusted for maternal age at
enrollment, ethnicity, educational level at intake, smoking at intake, and pre-pregnancy BMI. Additionally, we adjusted for retinal venular caliber when assessing
the outcome retinal arteriolar caliber and vice versa
Table 2 Subject characteristics 6 years after index pregnancy by gestational hypertensive disorder (n = 3391)
Normotensive Pregnancy GH PE P value
(n = 3183) (n = 145) (n = 63)
Maternal characteristics (follow-up)
Age (years) 36.7 (5.1) 37.1 (4.9) 36.0 (5.5) 0.38
Visit interval (years) 6.2 (5.7, 7.4) 6.1 (5.7, 7.6) 6.0 (5.7, 7.5) 0.30
Systolic blood pressure (mmHg) 118.1 (12.0) 128.4 (17.6) 126.5 (15.8) <0.001
Diastolic blood pressure (mmHg) 70.0 (9.3) 78.2 (12.0) 78.5 (12.4) <0.001
Mean arterial pressure (mmHg) 86.0 (9.6) 95.0 (13.2) 94.5 (12.9) <0.001
Hypertension (no., %) 203 (6.4) 39 26.9) 15 (23.8) <0.001
Primigravid (no., %) 225 (10.1) 19 (17.0) 9 (22.0) 0.003
Medication (no., %)
Cholesterol-lowering medication 8 (0.3) 1 (0.7) 0 (0.0) 0.55
Glucose-lowering medication 13 (0.4) 2 (1.4) 1 (1.6) 0.11
Anti-hypertensives 36 (1.1) 10 (6.9) 4 (6.3) <0.001
Cardiovascular medication 43 (1.4) 10 (6.9) 4 (6.3) <0.001
Combined 54 (1.7) 11 (7.6) 5 (7.9) <0.001
Smoking (no., %) 420 (18.9) 21 (18.9) 3 (7.3) 0.17
Retinal arteriolar caliber (μm) 145.8 (16.9) 141.9 (17.8) 137.8 (14.4) <0.001
Retinal venular caliber (μm) 207.1 (22.5) 208.6 (22.5) 203.8 (19.0) 0.36
Retinal arteriolar venular ratio 0.71 (0.07) 0.68 (0.07) 0.68 (0.06) <0.001
Weight (kg) 68.6 (53.6, 97.8) 77.0 (58.8, 121.1) 73.5 (53.3, 120.7) <0.001
Body mass index (kg/m2) 24.5 (19.7, 34.5) 27.7 (21.3, 45.5) 27.6 (19.6, 43.9) <0.001
Values are percentages for categorical variables, means (SD) for continuous variables with a normal distribution, or medians (90% range) for continuous variables
with a skewed distribution. Differences in baseline characteristics were tested using Student’s t test, ANOVA, Kruskal-Wallis, and chi-square tests. Values are
not imputed
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demonstrated that not only concurrent but also past el-
evated blood pressures are associated with retinal ar-
teriolar narrowing [30–32]. Therefore, retinal arteriolar
narrowing may not only be considered a transient re-
sponse to an increased blood pressure, but also the re-
sult of cumulative exposure to hypertension over the
life course. The underlying pathophysiology might be
explained by accumulating endothelial damage, due to
hypertension, eventually leading to endothelial dysfunc-
tion and microvascular impairment [33, 34].
This might also explain the larger retinal venular cali-
bers in women with previous GH in our study and not
in women with previous PE. GH women had a higher
weight and blood pressure at the start of pregnancy than
PE women. These factors have been associated with
larger retinal venular calibers, possibly through local vas-
cular inflammation and endothelial damage [35, 36].
Though we did not reach statistical significance, retinal
venular calibers also tended to be larger in women with
previous PE than in women with a previous normoten-
sive pregnancy. Nevertheless, we need to be causative in
interpreting this finding due to the small sample size of
women with previous PE.
Even though previous studies did not examine retinal
microvascular calibers both before and after GHD preg-
nancies, it seems likely that damage to the endothelium
as a result of the GHD is not completely reversible and
therefore enhances retinal microvascular changes after
pregnancy. Previous studies showed through flickering
response and the laser Doppler perfusion imaging tech-
nique in women with PE that retinal microvascular func-
tion is impaired both during pregnancy and up to
25 years after [9, 37]. Microvascular dysfunction there-
fore does not merely seem to be a disorder of pregnancy.
For this reason, future research should aim to visualize
the retinal microvasculature, before and at multiple time
points after GHD, in order to detect if retinal
microvascular abnormalities precede the onset of GHD
and whether they progress after pregnancy.
Numerous studies have shown a relationship between
retinal vascular changes (e.g., retinal arteriolar narrowing
and retinal venular widening) and future CVD [5, 32,
38–40]. For instance, a large meta-analysis showed an
increased risk of coronary heart disease (CHD) in
women with wider retinal venular or narrower retinal
arteriolar calibers [41]. The Atherosclerosis Risk in
Communities Study (ARIC) assessed retinal microvascu-
lar calibers among men and women aged 49–73 and
showed that retinal arteriolar narrowing was associated
with an increased risk of CHD, myocardial infarction,
congestive heart failure, and incident hypertension
[32, 38, 39]. Additionally, the Beaver Dam Eye Study
demonstrated that retinal arteriolar narrowing is asso-
ciated with an increased 10-year risk of hypertension
[42]. Our study provides evidence to support the con-
cept that women with GHD show more unfavorable
retinal microvascular calibers 6 years after pregnancy
than women with previous normotensive pregnancies. As
a result, it is reasonable to speculate that women with
GHD might have an increased risk for future CVD.
Strengths and limitations
Several limitations of the present studies need to be dis-
cussed. First, we did not obtain retinal vascular imaging
from 33.6% of all women who came for follow-up visits
6 years after pregnancy, because retinal vascular imaging
was introduced into the Generation R Study after re-
cruitment of study subjects had already started. As this
was independent of any subject characteristics, we do
not expect any additional selection bias. However, there
may be some loss of power due to a smaller sample size
available for our analysis and hence larger confidence in-
tervals of the reported associations. Second, compared
to non-responders (43%) study participants were on
Table 4 The mediation role of mean arterial pressure at the time of retinal imaging in the association of gestational hypertensive
disorders with retinal vascular calibers 6 years after index pregnancy (n = 3391)
Normotensive pregnancy
(n = 3183)
Gestational hypertension (n = 145)
Beta (95% CI)
P value Pre-eclampsia (n = 63)
Beta (95% CI)
P value
Retinal arteriolar caliber (SDS)
Total effect Ref –0.20 (–0.35, –0.05) 0.01 –0.41 (–0.62, –0.21) <0.001
Direct effect Ref –0.01 (–0.14, 0.13) 0.94 –0.21 (–0.41, –0.02) 0.03
Mediated effect Ref –0.20 (–0.26, –0.13) <0.001 –0.20 (–0.29, –0.11) <0.001
Retinal venular caliber (SDS)
Total effect Ref 0.22 (0.08, 0.36) <0.001 0.08 (–0.09, 0.27) 0.39
Direct effect Ref 0.16 (0.02, 0.30) 0.02 0.03 (–0.14, 0.22) 0.76
Mediated effect Ref 0.06 (0.03, 0.09) <0.001 0.05 (0.02, 0.09) <0.001
CI confidence interval, Ref reference, SDS standard deviation score, BMI body mass index
Values are regression coefficients (95% CI) and are based on mediation analysis. Values are adjusted for maternal age at enrollment, ethnicity, educational level at intake,
smoking at intake, and pre-pregnancy BMI. Additionally, we adjusted for retinal venular caliber when assessing the outcome retinal arteriolar caliber and vice versa
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average older at study enrollment, more often primipar-
ous and of European descent, higher educated, more
often non-smokers, and more often had GH. This may
have led to some degree of selection bias, as the in-
cluded women were relatively healthy, and may have led
to an underestimation of the association between GHD
and retinal microvasculature. Third, due to unavailability
of pre-pregnancy data on blood pressure (as is also the
case in most other studies focusing on pregnant women
and cardiovascular outcomes after pregnancy), we can-
not exclude the possibility that microvascular changes
and hypertension preceded the onset of GHD. However,
we compensated for this by excluding women with
chronic hypertension. Information on chronic hyperten-
sion before pregnancy was obtained through a question-
naire during pregnancy, which was cross-checked with
information from the original medical records and the
Dutch obstetric database [43]. Our results did not
change significantly after we performed a sensitivity ana-
lysis excluding women with hypertension in early preg-
nancy (13.2 weeks of gestation, 95% CI; 11.1–17.0) or
women with hypertension at the time of retinal imaging.
Hypertension in early pregnancy was defined as a sys-
tolic blood pressure ≥140 mmHg and/or a diastolic
blood pressure ≥90 mmHg. Hypertension at the time of
retinal imaging was defined as the intake of antihyperten-
sive medication and a systolic blood pressure ≥140 mmHg
and/or a diastolic blood pressure ≥90 mmHg. Lowering
the cut-off for hypertension at the time of retinal imaging
(systolic blood pressure ≥130 mmHg and/or diastolic
blood pressure ≥80 mmHg) did not change the direction
of our results, but did attenuate our results to non-
significant levels. Fourth, retinal vascular calibers were not
assessed before pregnancy. Therefore, microvascular
changes might be due to GHD or might have predated
pregnancy. Fifth, the observational nature of this study
does not allow for inference of causality and does not pre-
clude the existence of residual confounding. Sixth, infor-
mation on pregnancies and GHD occurring after the
index pregnancy was incomplete. The absence of these
data might have affected our results. Finally, our study also
has several strengths. First, this is a prospective cohort
study from early pregnancy onwards with a large sample
size of 3391 participants. Second, retinal images were
taken and graded following standardized protocols.
Conclusions
Our study shows that in women with GHD the micro-
vasculature is already affected early in life. Six years after
the index pregnancy, women with GHD show smaller
retinal arteriolar and wider retinal venular calibers than
women with a normotensive pregnancy, suggesting that
the changes in the microvasculature possibly represent
the pathophysiological substrate linking GHD to CVD in
later life. Future research should therefore aim to inves-
tigate associations between the microvasculature and
cardiovascular risk factors before and after the onset of
GHD and the long-term cardiovascular outcomes in
these women.
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Additional file 1: Maternal and fetal characteristics stratified for loss to
follow-up (n = 5966). (DOCX 15 kb)
Additional file 2: Figure S1. The association of gestational hypertensive
disorders with retinal arteriolar (A) and venular (B) calibers 6 years after index
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